Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease
- 1 March 1997
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (3), 320-325
- https://doi.org/10.1007/bf01728771
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body diseaseNeurology, 1996
- Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonismAnnals of Neurology, 1995
- Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1994
- The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT)The British Journal of Psychiatry, 1994
- The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane.1994
- SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brainJournal of Neural Transmission, 1993
- Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.1992
- Clinical Use of SPET Imaging in Psychiatric and Neurological DiseasePublished by Springer Science and Business Media LLC ,1991
- Clinical and Pathological Aspects of Parkinsonism in Alzheimer's DiseaseArchives of Neurology, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984